908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel Hill, […]

Menlo Ventures leads Series C to power global expansion, extend product lead and deepen commercial relationships to accelerate biotech breakthroughs SAN FRANCISCO — Benchling, the leading life sciences R&D cloud platform, announced it closed $34.5 million in Series C funding led by Menlo Ventures with new investors Lead Edge Capital and Y Combinator Continuity as well as returning investors […]

Investment led by BeauVest Group and Roadmap Capital endorses the visionary approach of Tornado’s chemical analysis & measurement solutions TORONTO – Tornado Spectral Systems Inc., a leading manufacturer of Raman analyzers for real-time process monitoring, today announced it has closed its latest round of Series A financing bringing a total of $10.2 million in new investment.  The funding […]

CDD Awarded Phase 1 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 1 SBIR grant from NIH NCATS, titled: “Novel Deep Learning Strategy to Better Predict Pharmacological Properties of […]

Revises 2019 Full Year Revenue Guidance SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance. Subject to quarter-end closing adjustments, the Company expects to report second quarter revenue of approximately $835 million, compared to $830 million in the second quarter of 2018. The Company’s second […]

DRVISION wins up to 3.27 million USD NIMH SBIR grant to develop the Intelligent Connectomics Analysis platform within Aivia BELLEVUE, WA, UNITED STATES — DRVISION Technologies, a pioneer in computer vision and the world’s leading AI microscopy software company has been awarded up to 3.27 million USD from the National Institute of Mental Health (NIMH) to […]

CAMBRIDGE (UK) – Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing. Nidobirds Ventures, after successful investment in Labstep, joined local angel investors and industry veterans in the funding round. The funds will be […]

In a filing with the U.S. Security and Exchange Commission, the company reported that 12 investors participated in the funding round, which required no minimum investment. CEO Gary Pace, Ph.D., J.D., said that Cell Microsystems would use the funding to build out its commercial team with support and manufacturing personnel, as well as add sales […]

ST. PETERSBURG, Fla. — SRI International has been awarded a multi-year $11.6 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop advanced chemical sensors that can support detection of chemical threats in complex urban environments. The system, called Localization and Characterization of Chemical Anomalies in Urban Settings (LOCCUS), will be developed under DARPA’s SIGMA+ Program. LOCCUS will be […]

CAMBRIDGE, Mass – Ultivue, the innovation leader in tissue biomarker identification and quantification assays for translational and pathology research labs, today announced the close of a $22 Million Series C funding led by new investor Northpond Ventures and fueled by existing investors including ARCH Venture Partners, 6 Dimensions Capital, Yonghua Capital, and Applied Ventures. The […]